Furthermore, downregulation of ING3 in prostate cancer cell lines resulted in reduced growth along with upregulation in a cohort of prostate cancer tissues suggesting an oncogenic role in progression of prostate cancer metastases [23]. The gene discussed is ING3; the disease is prostate carcinoma.